HomeNXTCL • STO
add
NextCell Pharma AB
Previous close
kr 1.21
Day range
kr 1.17 - kr 1.29
Year range
kr 0.63 - kr 3.24
Market cap
133.45M SEK
Avg Volume
267.05K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Aug 2025info | Y/Y change |
|---|---|---|
Revenue | 1.83M | -41.01% |
Operating expense | 9.11M | 11.08% |
Net income | -13.79M | -51.40% |
Net profit margin | -342.26 | -16.32% |
Earnings per share | — | — |
EBITDA | -13.26M | -2.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Aug 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.03M | -44.36% |
Total assets | 63.92M | -21.37% |
Total liabilities | 13.32M | -2.71% |
Total equity | 66.39M | — |
Shares outstanding | 111.39M | — |
Price to book | 2.69 | — |
Return on assets | -34.10% | — |
Return on capital | -40.91% | — |
Cash Flow
Net change in cash
| (SEK) | Aug 2025info | Y/Y change |
|---|---|---|
Net income | -13.79M | -51.40% |
Cash from operations | -9.37M | -36.77% |
Cash from investing | -1.03M | -175,382.79% |
Cash from financing | 34.52M | 1.68% |
Net change in cash | -10.08M | -51.59% |
Free cash flow | -9.37M | -187.58% |
About
Founded
2014
Website
Employees
24
